(Q39459344)

English

Watchful waiting or watchful progression?: Prostate specific antigen doubling times and clinical behavior in patients with early untreated prostate carcinoma.

scientific article published on January 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9445192%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Watchful waiting or watchful progression?: Prostate specific antigen doubling times and clinical behavior in patients with early untreated prostate carcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9445192%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9445192%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

author name string

M McKenzie

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9445192%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

G Duncan

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9445192%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

T Pickles

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9445192%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

language of work or name

0 references

publication date

1 January 1998

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9445192%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9445192%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

82

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9445192%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9445192%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

342-348

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9445192%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Histologic differentiation, cancer volume, and pelvic lymph node metastasis in adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980115%2982%3A2%3C349%3A%3AAID-CNCR15%3E3.0.CO%3B2-Z

21 January 2018

Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980115%2982%3A2%3C349%3A%3AAID-CNCR15%3E3.0.CO%3B2-Z

21 January 2018

Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980115%2982%3A2%3C349%3A%3AAID-CNCR15%3E3.0.CO%3B2-Z

21 January 2018

Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980115%2982%3A2%3C349%3A%3AAID-CNCR15%3E3.0.CO%3B2-Z

21 January 2018

Observations on the doubling time of prostate cancer. The use of serial prostate-specific antigen in patients with untreated disease as a measure of increasing cancer volume

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980115%2982%3A2%3C349%3A%3AAID-CNCR15%3E3.0.CO%3B2-Z

21 January 2018

Metaphase cytogenetics and DNA flow cytometry with analysis of S-phase fraction in prostate cancer: influence on prognosis

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980115%2982%3A2%3C349%3A%3AAID-CNCR15%3E3.0.CO%3B2-Z

21 January 2018

bl-2 [corrected] Expression on prostate cancer and its relationship to cell cycle and prognosis

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980115%2982%3A2%3C349%3A%3AAID-CNCR15%3E3.0.CO%3B2-Z

21 January 2018

Prostate-specific antigen as a prognostic factor for prostate cancer treated by external beam radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980115%2982%3A2%3C349%3A%3AAID-CNCR15%3E3.0.CO%3B2-Z

21 January 2018

Pretreatment prostate-specific antigen doubling times: clinical utility of this predictor of prostate cancer behavior

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980115%2982%3A2%3C349%3A%3AAID-CNCR15%3E3.0.CO%3B2-Z

21 January 2018

Prostatic-specific antigen doubling times in patients with prostate cancer: a potentially useful reflection of tumor doubling time

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980115%2982%3A2%3C349%3A%3AAID-CNCR15%3E3.0.CO%3B2-Z

21 January 2018

Observations of pretreatment prostate-specific antigen doubling time in 107 patients referred for definitive radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980115%2982%3A2%3C349%3A%3AAID-CNCR15%3E3.0.CO%3B2-Z

21 January 2018

Histologic grading study of prostate adenocarcinoma: the development of a new system and comparison with other methods--a preliminary study

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980115%2982%3A2%3C349%3A%3AAID-CNCR15%3E3.0.CO%3B2-Z

21 January 2018

Linear regressive analysis using prostate-specific antigen doubling time for predicting tumor biology and clinical outcome in prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980115%2982%3A2%3C349%3A%3AAID-CNCR15%3E3.0.CO%3B2-Z

21 January 2018

Relationship of tumor DNA-ploidy to serum prostate-specific antigen doubling time after radiotherapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980115%2982%3A2%3C349%3A%3AAID-CNCR15%3E3.0.CO%3B2-Z

21 January 2018

Overexpression of Her-2/neu may be an indicator of poor prognosis in prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980115%2982%3A2%3C349%3A%3AAID-CNCR15%3E3.0.CO%3B2-Z

21 January 2018

Identifiers

10.1002/(SICI)1097-0142(19980115)82:2<349::AID-CNCR15>3.0.CO;2-Z

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9445192%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9445192%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39459344&oldid=2081198591"